KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Payables (2016 - 2026)

National Health Investors filings provide 18 years of Payables readings, the most recent being $82.5 million for Q1 2026.

  • On a quarterly basis, Payables rose 15.79% to $82.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $82.5 million, a 15.79% increase, with the full-year FY2025 number at $88.2 million, up 11.79% from a year prior.
  • Payables hit $82.5 million in Q1 2026 for National Health Investors, down from $88.2 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $88.2 million in Q4 2025 to a low of $60.4 million in Q1 2022.
  • Median Payables over the past 5 years was $71.2 million (2025), compared with a mean of $71.3 million.
  • Biggest five-year swings in Payables: dropped 18.65% in 2022 and later increased 15.79% in 2026.
  • National Health Investors' Payables stood at $65.0 million in 2022, then grew by 12.96% to $73.4 million in 2023, then rose by 7.5% to $78.9 million in 2024, then grew by 11.79% to $88.2 million in 2025, then decreased by 6.48% to $82.5 million in 2026.
  • The last three reported values for Payables were $82.5 million (Q1 2026), $88.2 million (Q4 2025), and $78.5 million (Q3 2025) per Business Quant data.